PharVision Advisers’s Clearfield CLFD Stock Holding History

PharVision Advisers’s Portfolio CLFD Stock Details CLFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,098	Closed	-$244K	–	732
2025 Q3	$244K	Buy	+7,098	New	+$264K	0.14%	351

Other funds holding CLFD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

PharVision Advisers's CLFD Position: Q4 2025 in Review

PharVision Advisers sold out of Clearfield (CLFD) in Q4 2025, closing a stake of 7,098 shares — an estimated $244K sold.

PharVision Advisers first reported a position in CLFD in Q3 2025 and held it in 1 quarter. The position peaked at $244K in Q3 2025. 125 funds tracked by Wall St. Rank hold CLFD as of Q4 2025.

PharVision Advisers reported no remaining Clearfield position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 7,098 Clearfield shares in Q4 2025, an estimated $244K.
PharVision Advisers first reported a position in Clearfield in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Clearfield position peaked at $244K in Q3 2025.
125 funds tracked by Wall St. Rank held Clearfield as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.